It is estimated that 5.5 million Americans are living with Alzheimer’s dementia in 2017. Alzheimer’s is the most common form of dementia that causes problems with memory, thinking, and behavior. There are ways to slow the worsening of dementia and improve quality of life; however, there are no prevailing treatments to stop the progression of Alzheimer’s. Today, there is a worldwide effort taking place to find better treatments and prevention. The following four companies are committed to different aspects of helping those affected by the disease and their loved ones.
This organization is a leading voluntary health organization in Alzheimer’s research, support, and care. Their mission is to eliminate the disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia by promoting brain health. For care and support, the organization has local chapters across America within each community. They host face-to-face support and educational sessions nationwide and provide comprehensive online resources, such as tools for those facing the disease to create an action plan for care, and an online community for families and caregivers to connect, discuss, and research.
This organization is family owned and operated with a whopping ten employees. Originated in 1999, Care Pathways helps families search for quality care of their loved ones. Founded by Clare Absher, RN, BSN, and Jeff Absher, BS, Care Pathways was created to help families find the best care for their loved ones. The website offers information on home care, assisted living, retirement homes, adult day care and types of caregivers, and it provides tools to find the kind of care you need near in your area.
Alzheimer’s Drug Discovery Foundation (ADDF)
As you may have guessed, this mission of this organization is to accelerate the discovery of drugs to prevent, treat, and cure Alzheimer’s disease. Leonard A. and Ronald S. Lauder founded ADDF in 1998. It is the only charity that is focused solely on funding breakthrough research for the disease. The organization supports preclinical drug discovery and early-stage clinical trials; the development of the drug is not far enough along at this point to attract funding from pharmaceutical companies or government grants. The ADDF hopes to enable scientists pursuing new ideas for cures that would otherwise be unseen.
Us Against Alzheimer’s
Us Against Alzheimer’s is an organization committed to ending Alzheimer’s by 2020. The National Plan is to find a cure for the disease by 2025, but US Against Alzheimer’s, along with millions of affected families, feel that 2025 is too long of a wait. To achieve their goals, the organization is working to increase public resources committed to finding a cure, accelerate the drug development process, and create significant improvements to the standards and systems for caring for those living with the disease and their families.